Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 27.09.2024
Dexus Finance Pty Limited
Dexus (ASX: DXS)
ASX release
27 September 2024
2024 Notice of Annual General Meeting
Dexus today confirmed details relating to its 2024 Annual General Meeting (AGM).
The 2024 AGM will be a hybrid meeting, with Security holders invited to join the meeting in person or attend virtually on Wednesday 30 October 2024, commencing at 2.00pm (AEDST) [ … ]
Thu, 26.09.2024
coinIX GmbH & Co. KGaA
The Hamburg-based investment company coinIX GmbH & Co. KGaA has presented its interim financial statement as of June 30, 2024. With a significant increase from EUR 347k in the previous year to EUR 791k, the revenue situation has improved noticeably. Write-downs on existing investments totaling EUR 394k were made, and other operating expenses in [ … ]
Thu, 26.09.2024
HELLA GmbH & Co. KGaA
LIPPSTADT (GERMANY)
26 September 2024
FORVIA HELLA adjusts company outlookfor fiscal year 2024
Adjusted forecast is caused by lower-than-expected production volumes, customer-related postponements of series launches as well as customer and product mix effects
Measures to further improve cost structures, particularly in Europe, a [ … ]
Thu, 26.09.2024
HELLA GmbH & Co. KGaA
HELLA GmbH & Co KGaA ("FORVIA HELLA") has adjusted the company outlook for the fiscal year 2024 after analyzing current data: For the current year, currency and portfolio-adjusted sales of between around 7.9 and 8.1 billion euros (previously: in the lower half of the range of around 8.1 and 8.6 billion euros), an operating income margin of betw [ … ]
Thu, 26.09.2024
Affluent Medical SA
PRESS RELEASE
H1 2024 RESULTS
Major advances in all three programs
Several strategic agreements signed with the world medtech leader in cardiology
Extension of financial runway to July 2025
Several agreements signed in July 2024 with Edwards Lifesciences for an initial amount of €15m and an option to acquire the rights for KaliosTM
Positiv [ … ]
Thu, 26.09.2024
Aquis Stock Exchange
The following securities are suspended from trading on the Aquis Growth Market with immediate effect:
Essentially Group PLC
Ordinary Shares
Symbol: ESSN
ISIN: GB00BKS7D362
The Regulation Department
Aquis Stock Exchange
Floor 2, 63 Queen Victoria Street, EC4N 4UA
Tel: 0203 597 6361
Email: aqseregulation@aquis.eu
Website: www.aquis.eu/aquis-stock-exc [ … ]
Thu, 26.09.2024
AT&S Austria Technologie & Systemtechnik AG
AT&S CEO function to be newly advertised
As previously reported, Andreas Gerstenmayer has resigned from his position as CEO of AT&S for personal reasons with effect from Oct. 1, 2024. On an interim basis, Dr. Peter Schneider – previously Deputy CEO – will take on the role of “Spokesman of the Management Board”. Until the new CEO is appoin [ … ]
Thu, 26.09.2024
Aurubis AG
Aurubis demonstrates sustainable metal production with extensive the Copper Mark certification
Following the Copper Mark certification of the Aurubis sites Beerse and Stolberg, more than 95 % of Aurubis cathode output fulfills the standards of this assurance framework
Aurubis Stolberg is the first rolling mill in the world with the Copper Mark d [ … ]
Thu, 26.09.2024
Mercedes-Benz Australia/Pacific Pty Ltd
The interim financial report for the half year ended 30 June 2024 of Mercedes-Benz Australia/Pacific Pty. Ltd. is available onhttps://group.mercedes-benz.com/investors/refinancing/bonds/issuers-reports/australia-pacific/
This is regulated information according to the publication requirements of the Transparency Law and related regulations of Luxemb [ … ]
Thu, 26.09.2024
Mutares SE & Co. KGaA
Mutares' first statement on Gotham City's research report and the short attack – insight into current business performance and short and medium-term outlook
Munich, 26 September 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) ("Mutares") has today received the report of Gotham City Research and issues the following initial statement:
Commerc [ … ]